Onconova Therapeutics, Inc.·4

Oct 27, 4:41 PM ET

Moyo Victor M 4

4 · Onconova Therapeutics, Inc. · Filed Oct 27, 2023

Insider Transaction Report

Form 4
Period: 2023-10-02
Moyo Victor M
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock Option (right to purchase)

    2023-10-02+125,000125,000 total
    Exercise: $0.74Exp: 2033-10-02Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]These options vest over 4 years, 25% on the first anniversary of the grant and thereafter in 36 equal monthly installments over the next 3 years.

Documents

1 file
  • 4
    form4-10272023_081005.xmlPrimary